COMPUTERGESTEUERTER MOBILER MESSPLATZ FUER MILITAERFUNKGERAETE. = INSTALLATION MOBILE DE MESURE, COMMANDEE PAR ORDINATEUR, POUR APPAREILS DE RADIO MILITAIRESWETTSTEIN J; BANI M.1978; BULL. ASS. SUISSE ELECTRICIENS; CHE; DA. 1978; VOL. 69; NO 10; PP. 508-509; ABS. FRE; BIBL. 3 REF.Article

ABSORPTION OF IRON IN YOUNG MEN STUDIED BY MONITORING EXCRETION OF A STABLE IRON ISOTOPE (⁵⁸FE) IN FECESJANGHOR BANI M; TING BTG; YOUNG VR et al.1980; J. NUTR.; ISSN 0022-3166; USA; DA. 1980; VOL. 110; NO 11; PP. 2190-2197; BIBL. 9 REF.Article

Differentiation of central and peripheral cholecystokinin receptors by new glutaramic acid derivatives with cholecystokinin-antagonistic activityMAKOVEC, F; BANI, M; CHISTE, R et al.Arzneimittel-Forschung. 1986, Vol 36, Num 1, pp 98-102, issn 0004-4172Article

New glutamic and aspartic derivatives with potent CCK-antagonistic activityMAKOVIC, F; CHISTE, R; BANI, M et al.European journal of medicinal chemistry. 1986, Vol 21, Num 1, pp 9-20, issn 0223-5234Article

Metabolism-based drug interactions involving oral azole antifungals in humansBENEDETTI, M. S; BANI, M.Drug metabolism reviews (Softcover ed.). 1999, Vol 31, Num 3, pp 665-717, issn 0360-2532Conference Paper

Hereditäres Mamma- und Ovarialkarzinom: ein Update. Teil I - molekulare Grundlagen, Tumorrisikoberatung und Risikoberechnung = Hereditary breast and ovarian cancer: an update. Part I - Molecular basics, genetic counselling and risk calculationFASCHING, P. A; LUX, M. P; BANI, M et al.Geburtshilfe und Frauenheilkunde. 2004, Vol 64, Num 9, pp 900-911, issn 0016-5751, 12 p.Article

Taxonomic relationships between four species of the Mullidae family revealed by three genetic methods: allozymes, random amplified polymorpic DNA and mitochondrial DNAMAMURIS, Z; STAMATIS, C; BANI, M et al.Journal of fish biology. 1999, Vol 55, Num 3, pp 572-587, issn 0022-1112Article

Novel aryloxyalkylthioimidazoles as inhibitors of acyl-CoA: cholesterol-O-acyltransferaseBANI, M; BORMETTI, R; VANOTTI, E et al.European journal of medicinal chemistry. 1995, Vol 30, Num 1, pp 39-46, issn 0223-5234Article

Protective effect of CR 1409 (cholecystokinin antagonist) on experimental pancreatitis in rats and miceMAKOVEC, F; BANI, M; CEREDA, R et al.Peptides (New York, NY. 1980). 1986, Vol 7, Num 6, pp 1159-1164, issn 0196-9781Article

Verdacht auf Mammakarzinom (BI-RADS 5) : Einsatz der sonographisch geführten Vakuumbiopsie (LCNB) nach histologisch primär negativer konventioneller Hochgeschwindigkeitsstanzbiopsie (CNB) = Suspicion of breast cancer (BI-RADS 5) : evaluation of sonographically guided vacuum-assisted large core needle biopsy (LCNB) after primary negative conventional core needle biopsy (CNB)SCHULZ-WENDTLAND, R; BOCK, K; WENKEL, E et al.Geburtshilfe und Frauenheilkunde. 2005, Vol 65, Num 8, pp 767-771, issn 0016-5751, 5 p.Article

Association of cytochrome P450 induction with oxidative stress in vivo as evidenced by 3-hydroxylation of salicylateSTROLIN-BENEDETTI, M; BROGIN, G; BANI, M et al.Xenobiotica (London. Print). 1999, Vol 29, Num 11, pp 1171-1180, issn 0049-8254Article

Antispasmodic activity on the gallbladder of the mouse of CR 1409 (Lorglumide) a potent antagonist of peripheral CCKMAKOVEC, F; BANI, M; CEREDA, R et al.Pharmacological research communications. 1987, Vol 19, Num 1, pp 41-51, issn 0031-6989Article

Anticholecystokinin activities of loxiglumideSETNIKAR, I; BANI, M; CEREDA, R et al.Arzneimittel-Forschung. 1987, Vol 37, Num 10, pp 1168-1171, issn 0004-4172Article

Hereditäres Mamma- und Ovarialkarzinom: ein Update. Teil II: Früherkennung, Prävention und Therapie = Hereditary breast and ovarian cancer: an update. Part II: Early cancer detection, prevention and therapyLUX, M. P; FASCHING, P. A; BANI, M et al.Geburtshilfe und Frauenheilkunde. 2004, Vol 64, Num 10, pp 1037-1051, issn 0016-5751, 15 p.Article

Loxiglumide protects against experimental pancreatitisSETNIKAR, I; BANI, M; CEREDA, R et al.Arzneimittel-Forschung. 1987, Vol 37, Num 10, pp 1172-1174, issn 0004-4172Article

Different peripheral and central antagonistic activity of new glutaramic acid derivatives on satiety induced by cholecystokinin in ratsMAKOVEC, F; BANI, M; CHISTE, R et al.Regulatory peptides. 1986, Vol 16, Num 3-4, pp 281-290, issn 0167-0115Article

New glutaramic acid derivatives with potent competitive and specific cholecystokinin-antagonistic activityMAKOVEC, F; CHISTE, R; BANI, M et al.Arzneimittel-Forschung. 1985, Vol 35, Num 7, pp 1048-1051, issn 0004-4172Article

A detailed evaluation method to identify sources of quantitative resistance to Fusarium oxysporum f. sp. pisi race 2 within a Pisum spp. germplasm collectionBANI, M; RUBIALES, D; RISPAIL, N et al.Plant pathology. 2012, Vol 61, Num 3, pp 532-542, issn 0032-0862, 11 p.Article

A double-blind, placebo-controlled study to assess tolerability, pharmacokinetics and preliminary pharmacodynamics of single escalating doses of Z13752A, a novel dual inhibitor of the metalloproteases ACE and NEP, in healthy volunteersBANI, M; COLANTONI, A; GUILLAUME, M et al.British journal of clinical pharmacology. 2000, Vol 50, Num 4, pp 338-349, issn 0306-5251Article

Involvement of CYP2D6 but not CYP2C19 in nicergoline metabolism in humansBOTTIGER, Y; DOSTERT, P; STROLIN BENEDETTI, M et al.British journal of clinical pharmacology. 1996, Vol 42, Num 6, pp 707-711, issn 0306-5251Article

8-Substituted purine derivatives : a new class of lipid-lowering agentsVANOTTI, E; BANI, M; FAVARA, D et al.European journal of medicinal chemistry. 1994, Vol 29, Num 4, pp 287-294, issn 0223-5234Article

Pharmacological characterisation of a new potent and specific nonpolypeptidic cholecystokinin antagonistSETNIKAR, I; BANI, M; CEREDA, R et al.Arzneimittel-Forschung. 1987, Vol 37, Num 6, pp 703-707, issn 0004-4172Article

Pharmacological properties of lorglumide as a member of a new class of cholecystokinin antagonistsMAKOVEC, F; BANI, M; CEREDA, R et al.Arzneimittel-Forschung. 1987, Vol 37, Num 11, pp 1265-1268, issn 0004-4172Article

Best approximation in L^∞ via iterative Hilbert space proceduresBANI, M. J; CHALMERS, B. L.Journal of approximation theory. 1984, Vol 42, Num 2, pp 173-180, issn 0021-9045Article

Silencing of the F11R gene reveals a role for F11R/JAM-A in the migration of inflamed vascular smooth muscle cells and in atherosclerosisAZARI, Bani M; MARMUR, Jonathan D; SALIFU, Moro O et al.Atherosclerosis. 2010, Vol 212, Num 1, pp 197-205, issn 0021-9150, 9 p.Article